Moderna vaccine being reviewed for WHO emergency listing on April 30 - WHO spokesman
Moderna's COVID-19 vaccine is being reviewed on April 30 by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters. "We are discussing the Moderna COVID-19 vaccine on Friday 30 April 2021,” WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker's vaccine was expected in one to four days after that, he said.
- Country:
- United States
Moderna's COVID-19 vaccine is being reviewed on April 30 by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters.
"We are discussing the Moderna COVID-19 vaccine on Friday 30 April 2021,” WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker's vaccine was expected in one to four days after that, he said. So far COVID-19 vaccines made by Pfizer, AstraZeneca, and Johnson & Johnson have already received WHO approval, which is a signal to national regulatory authorities on a product's safety and efficacy.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Health News Roundup: Pfizer RSV shot meets goals in trial of high-risk adults under age 60; Cuba says drug use on the rise, especially among youth and more
GLOBAL MARKETS-Asian shares fall on U.S. rate scare, yen plumbs 34-yr low
EMERGING MARKETS-Stocks, FX slide after U.S. inflation print triggers global selloff
GLOBAL MARKETS-Europe turns to ECB after U.S. inflation selloff
Russia and U.S. are in contact over non-deployment of nuclear weapons in space - TASS